SNDX
Syndax Pharmaceuticals Inc
NASDAQ: SNDX · HEALTHCARE · BIOTECHNOLOGY
$20.65
+2.74% today
Updated 2026-05-06
Market cap
$1.69B
P/E ratio
—
P/S ratio
7.79x
EPS (TTM)
$-2.79
Dividend yield
—
52W range
$9 – $26
Volume
1.6M
Syndax Pharmaceuticals Inc (SNDX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-112.00%
Operating margin
-52.70%
ROE
-189.50%
ROA
-25.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-13.09M | — | — | — |
| 2012 | — | $-9.96M | — | — | — |
| 2013 | — | $-14.17M | — | — | — |
| 2014 | $0.00 | $-19.83M | — | — | — |
| 2015 | $627000.00 | $-24.12M | 100.00% | -3,271.61% | -3,846.73% |
| 2016 | $1.22M | $-44.47M | 100.00% | -3,587.38% | -3,645.25% |
| 2017 | $2.11M | $-60.80M | 100.00% | -2,938.99% | -2,884.35% |
| 2018 | $1.52M | $-73.96M | 100.00% | -5,001.71% | -4,875.48% |
| 2019 | $1.52M | $-55.95M | 100.00% | -3,792.95% | -3,688.53% |
| 2020 | $1.52M | $-73.07M | 100.00% | -4,708.17% | -4,816.68% |
| 2021 | $139.71M | $24.93M | 100.00% | 18.77% | 17.84% |
| 2022 | $126.58M | $-143.75M | -0.36% | -119.89% | -113.57% |
| 2023 | $0.00 | $-209.36M | — | — | — |
| 2024 | $23.68M | $-318.76M | 96.51% | -1,434.43% | -1,346.11% |
| 2025 | $172.35M | $-285.42M | 95.96% | -158.45% | -165.60% |